Skip to main content
CAMBRIDGE COGNITION HOLDINGS PLC logo

CAMBRIDGE COGNITION HOLDINGS PLC — Investor Relations & Filings

Ticker · COG ISIN · GB00B8DV9647 LEI · 213800SZKDIN122EPA96 IL Professional, scientific and technical activities
Open in API
Filings indexed 368 across all filing types
Latest filing 2024-12-27 Director's Dealing
Country GB United Kingdom
Listing IL COG

About CAMBRIDGE COGNITION HOLDINGS PLC

https://www.cambridgecognition.com/

Cambridge Cognition Holdings PLC is a neuroscience technology company that develops and markets digital solutions to assess brain health. The company provides an end-to-end platform for Central Nervous System (CNS) clinical trials, featuring a suite of scientifically validated digital cognitive assessments. Its technologies include touchscreen tests, voice analysis, electronic questionnaires, and high-frequency testing, which can be deployed both in-clinic and remotely for decentralized trials. These tools are utilized by pharmaceutical companies, academic research institutions, and healthcare professionals to accelerate drug development and enhance the understanding and treatment of conditions affecting brain health. With over 30 years of scientific validation, its assessments are recognized for their sensitivity in detecting subtle cognitive changes across numerous therapeutic areas.

Recent filings

Filing Released Lang Actions
Director/PDMR Share Purchases
Director's Dealing Classification · 100% confidence The document is a formal notification released via RNS (RNS Number: 4875R) on December 27, 2024. The content explicitly details a 'Director/PDMR Share Purchase' by Debra Leeves, a Non-Executive Director. This involves reporting personal share transactions by company directors and executives (insider trades). This directly matches the definition for Director's Dealing (Code: DIRS). Although it is distributed via RNS, the specific content dictates the DIRS classification over the general RNS fallback.
2024-12-27 English
Director/PDMR Share Purchases
Director's Dealing Classification · 100% confidence The document is an official notification filed via RNS (RNS Number: 1766R) dated December 23, 2024. The content explicitly details a 'Director/PDMR Share Purchase' by Nick Rodgers, a Non-Executive Director, including the number of shares purchased, price, and resulting holding. This type of transaction report, detailing personal share dealings by directors or persons discharging managerial responsibilities (PDMRs), directly corresponds to the definition of Director's Dealing.
2024-12-23 English
Director/PDMR Share Purchases
Director's Dealing Classification · 100% confidence The document is a formal notification issued via RNS (Regulatory News Service) on December 16, 2024. The content explicitly details a 'Director/PDMR Share Purchase' transaction involving Stuart Gall, a Non-Executive Director. This type of insider transaction report, detailing the purchase of ordinary shares by a director, falls directly under the definition of Director's Dealing. The structure, including the RNS Number, issuer details, and the specific notification tables regarding transactions by persons discharging managerial responsibilities, confirms this classification. This is distinct from a general regulatory filing (RNS) because it fits the specific category DIRS.
2024-12-16 English
Trading Update
Earnings Release Classification · 100% confidence The document is identified by the RNS Number (4095P) and the presence of the 'RNS Number' header, indicating it is a regulatory announcement distributed via the London Stock Exchange's RNS service. The content provides a 'Trading update for year ending 31 December 2024 and an early outlook for 2025,' detailing expected revenue, adjusted EBITDA, order book, and cash position. This is a preliminary announcement of financial performance highlights, not the full annual report (10-K) or a comprehensive interim report (IR). It fits the definition of an Earnings Release (ER) as it announces key financial results for a period. Although it is distributed via RNS, the specific content points strongly to ER over the general fallback RNS code. FY 2024
2024-12-10 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled as 'RNS Number : 6727M' and uses the 'TR-1: Standard form for notification of major holdings'. This form details changes in voting rights held by an individual (Brett Gordon) crossing a threshold, which falls under insider trading or significant ownership changes. This type of filing is a regulatory notification. While it relates to director/insider activity, the specific form (TR-1) and the context of reporting a change in shareholding percentage (9.084317%) most closely aligns with the category for reporting personal share transactions by directors and executives, which is 'Director's Dealing' (DIRS). It is not a general regulatory filing (RNS) because a more specific category exists. It is not a Director's Dealing (DIRS) because the definition for DIRS is 'Report of personal share transactions by company directors and executives (insider trades)', and this is a notification of a major holding change, which is often reported separately or under a specific major shareholding notification rule, but given the options, DIRS is the closest fit for executive/insider share movement reporting, although MRQ (Major Shareholding Notification) is also a strong candidate. However, TR-1 forms are specifically about the notification of major holdings crossing thresholds, which is explicitly defined as 'Major Shareholding Notification' (MRQ). Therefore, MRQ is the most accurate classification.
2024-11-18 English
Monument Therapeutics secures £1m investment
Regulatory Filings Classification · 100% confidence The document starts with 'RNS Number' and contains information typical of a regulatory news service announcement from the London Stock Exchange (LSE). The content announces a specific corporate event: a spin-out company securing investment (£1.0 million) and the implications for the parent company (Cambridge Cognition Holdings plc). This type of material, which is a brief, timely announcement of a specific corporate action (financing/investment in a subsidiary), fits best under the general 'Regulatory Filings' category (RNS) as it is not a comprehensive report (10-K, IR), an earnings release (ER), or a management discussion (MDA). Although it relates to financing (CAP), RNS is the designated category for general regulatory announcements that don't fit the more specific report types, and this format is characteristic of an RNS release.
2024-11-06 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.